Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study
Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases if a patient taking certain medications has hypokalemia, hepatitis C, HIV, or abnormal T wave morphology. ObjectiveThe authors aimed to dete...
Gespeichert in:
Veröffentlicht in: | The American journal of psychiatry 2013-12, Vol.170 (12), p.1468-1476 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1476 |
---|---|
container_issue | 12 |
container_start_page | 1468 |
container_title | The American journal of psychiatry |
container_volume | 170 |
creator | R. Girardin, François Gex-Fabry, Marianne Berney, Patricia Shah, Dipen Gaspoz, Jean-Michel Dayer, Pierre |
description | Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases if a patient taking certain medications has hypokalemia, hepatitis C, HIV, or abnormal T wave morphology.
ObjectiveThe authors aimed to determine the prevalence of drug-induced long QT at admission to a public psychiatric hospital and to document the associated factors using a cross-sectional approach.MethodAll ECG recordings over a 5-year period were reviewed for drug-induced long QT (heart-rate corrected QT ≥500 ms and certain or probable drug imputability) and associated conditions. Patients with drug-induced long QT (N=62) were compared with a sample of patients with normal ECG (N=143).ResultsAmong 6,790 inpatients, 27.3% had abnormal ECG, 1.6% had long QT, and 0.9% qualified as drug-induced long QT case subjects. Sudden cardiac death was recorded in five patients, and torsade de pointes was recorded in seven other patients. Relative to comparison subjects, patients with drug-induced long QT had significantly higher frequencies of hypokalemia, hepatitis C virus (HCV) infection, HIV infection, and abnormal T wave morphology. Haloperidol, sertindole, clotiapine, phenothiazines, fluoxetine, citalopram (including escitalopram), and methadone were significantly more frequent in patients with drug-induced long QT. After adjustment for hypokalemia, HCV infection, HIV infection, and abnormal T wave morphology, the effects of haloperidol, clotiapine, phenothiazines, and citalopram (including escitalopram) remained statistically significant. Receiver operating characteristic curve analysis based on the number of endorsed factors per patient indicated that 85.5% of drug-induced long QT patients had two or more factors, whereas 81.1% of patients with normal ECG had fewer than two factors.ConclusionsDrug-induced long QT and arrhythmia propensity substantially increase when specific psychotropic drugs are administered to patients with hypokalemia, abnormal T wave morphology, HCV infection, and HIV infection. |
doi_str_mv | 10.1176/appi.ajp.2013.12060860 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1465864178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1465864178</sourcerecordid><originalsourceid>FETCH-LOGICAL-a479t-2da1b59459de0fd67f60770125e7b8676256d504fe523b1e70ad855cb3ca687c3</originalsourceid><addsrcrecordid>eNp9kU1r3DAQhkVpabZp_0IQlEIv3o4kS7J7C9s0XVhIwm4hORlZkhMtXtvRx2H762tnNwn00NMw8Mw7MzwInRGYEyLFNzUMbq62w5wCYXNCQUAh4A2aEc54Jikt3qIZANCs5Oz2BH0IYTu2wCR9j05ozkCwHGbozw-f7rNlZ5K2Bq_67h7fbLDr8LlJbcTXYa8fnIreabzsBhWd7WL4jjcPFvPsziqPF74PIVtbHV3fqRZfLC7xWntrOzeGXaWo-52dEl-y9ngdk9l_RO8a1Qb76VhP0e-fF5vFr2x1dblcnK8ylcsyZtQoUvMy56Wx0BghGwFSAqHcyroQUlAuDIe8sZyymlgJyhSc65ppJQqp2Sn6esgdfP-YbIjVzgVt21Z1tk-hIrnghciJLEb08z_otk9-_OqJKiVQwidKHCg9ve5tUw3e7ZTfVwSqyU412alGO9Vkp3q2Mw6eHeNTvbPmZexZxwh8OQIqaNU2XnXahVeuACqLnI0cO3BPi15v_P_6v7cPqMA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1469702158</pqid></control><display><type>article</type><title>Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study</title><source>MEDLINE</source><source>American Psychiatric Publishing Journals (1997-Present)</source><source>EZB Electronic Journals Library</source><creator>R. Girardin, François ; Gex-Fabry, Marianne ; Berney, Patricia ; Shah, Dipen ; Gaspoz, Jean-Michel ; Dayer, Pierre</creator><creatorcontrib>R. Girardin, François ; Gex-Fabry, Marianne ; Berney, Patricia ; Shah, Dipen ; Gaspoz, Jean-Michel ; Dayer, Pierre</creatorcontrib><description>Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases if a patient taking certain medications has hypokalemia, hepatitis C, HIV, or abnormal T wave morphology.
ObjectiveThe authors aimed to determine the prevalence of drug-induced long QT at admission to a public psychiatric hospital and to document the associated factors using a cross-sectional approach.MethodAll ECG recordings over a 5-year period were reviewed for drug-induced long QT (heart-rate corrected QT ≥500 ms and certain or probable drug imputability) and associated conditions. Patients with drug-induced long QT (N=62) were compared with a sample of patients with normal ECG (N=143).ResultsAmong 6,790 inpatients, 27.3% had abnormal ECG, 1.6% had long QT, and 0.9% qualified as drug-induced long QT case subjects. Sudden cardiac death was recorded in five patients, and torsade de pointes was recorded in seven other patients. Relative to comparison subjects, patients with drug-induced long QT had significantly higher frequencies of hypokalemia, hepatitis C virus (HCV) infection, HIV infection, and abnormal T wave morphology. Haloperidol, sertindole, clotiapine, phenothiazines, fluoxetine, citalopram (including escitalopram), and methadone were significantly more frequent in patients with drug-induced long QT. After adjustment for hypokalemia, HCV infection, HIV infection, and abnormal T wave morphology, the effects of haloperidol, clotiapine, phenothiazines, and citalopram (including escitalopram) remained statistically significant. Receiver operating characteristic curve analysis based on the number of endorsed factors per patient indicated that 85.5% of drug-induced long QT patients had two or more factors, whereas 81.1% of patients with normal ECG had fewer than two factors.ConclusionsDrug-induced long QT and arrhythmia propensity substantially increase when specific psychotropic drugs are administered to patients with hypokalemia, abnormal T wave morphology, HCV infection, and HIV infection.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/appi.ajp.2013.12060860</identifier><identifier>PMID: 24306340</identifier><identifier>CODEN: AJPSAO</identifier><language>eng</language><publisher>Arlington, VA: American Psychiatric Association</publisher><subject>Adolescent ; Adult ; Aged ; Antipsychotic Agents - adverse effects ; Biological and medical sciences ; Case-Control Studies ; Citalopram - adverse effects ; Cross-Sectional Studies ; Death, Sudden, Cardiac - epidemiology ; Electrocardiography ; Electrocardiography - drug effects ; Female ; General aspects ; Humans ; Inpatient care ; Inpatients - psychology ; Long QT Syndrome - chemically induced ; Long QT Syndrome - complications ; Long QT Syndrome - epidemiology ; Male ; Medical sciences ; Mental Disorders - complications ; Mental Disorders - drug therapy ; Mental health care ; Methadone - adverse effects ; Middle Aged ; Pharmacology ; Prevalence ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Risk Factors ; Side effects ; Switzerland - epidemiology ; Torsades de Pointes - chemically induced ; Torsades de Pointes - epidemiology</subject><ispartof>The American journal of psychiatry, 2013-12, Vol.170 (12), p.1468-1476</ispartof><rights>Copyright © 2013 by the American Psychiatric Association 2013</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 by the American Psychiatric Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a479t-2da1b59459de0fd67f60770125e7b8676256d504fe523b1e70ad855cb3ca687c3</citedby><cites>FETCH-LOGICAL-a479t-2da1b59459de0fd67f60770125e7b8676256d504fe523b1e70ad855cb3ca687c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/appi.ajp.2013.12060860$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/appi.ajp.2013.12060860$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,776,780,2842,21605,21606,21607,27901,27902,77536,77541</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28027843$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24306340$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>R. Girardin, François</creatorcontrib><creatorcontrib>Gex-Fabry, Marianne</creatorcontrib><creatorcontrib>Berney, Patricia</creatorcontrib><creatorcontrib>Shah, Dipen</creatorcontrib><creatorcontrib>Gaspoz, Jean-Michel</creatorcontrib><creatorcontrib>Dayer, Pierre</creatorcontrib><title>Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases if a patient taking certain medications has hypokalemia, hepatitis C, HIV, or abnormal T wave morphology.
ObjectiveThe authors aimed to determine the prevalence of drug-induced long QT at admission to a public psychiatric hospital and to document the associated factors using a cross-sectional approach.MethodAll ECG recordings over a 5-year period were reviewed for drug-induced long QT (heart-rate corrected QT ≥500 ms and certain or probable drug imputability) and associated conditions. Patients with drug-induced long QT (N=62) were compared with a sample of patients with normal ECG (N=143).ResultsAmong 6,790 inpatients, 27.3% had abnormal ECG, 1.6% had long QT, and 0.9% qualified as drug-induced long QT case subjects. Sudden cardiac death was recorded in five patients, and torsade de pointes was recorded in seven other patients. Relative to comparison subjects, patients with drug-induced long QT had significantly higher frequencies of hypokalemia, hepatitis C virus (HCV) infection, HIV infection, and abnormal T wave morphology. Haloperidol, sertindole, clotiapine, phenothiazines, fluoxetine, citalopram (including escitalopram), and methadone were significantly more frequent in patients with drug-induced long QT. After adjustment for hypokalemia, HCV infection, HIV infection, and abnormal T wave morphology, the effects of haloperidol, clotiapine, phenothiazines, and citalopram (including escitalopram) remained statistically significant. Receiver operating characteristic curve analysis based on the number of endorsed factors per patient indicated that 85.5% of drug-induced long QT patients had two or more factors, whereas 81.1% of patients with normal ECG had fewer than two factors.ConclusionsDrug-induced long QT and arrhythmia propensity substantially increase when specific psychotropic drugs are administered to patients with hypokalemia, abnormal T wave morphology, HCV infection, and HIV infection.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Citalopram - adverse effects</subject><subject>Cross-Sectional Studies</subject><subject>Death, Sudden, Cardiac - epidemiology</subject><subject>Electrocardiography</subject><subject>Electrocardiography - drug effects</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Inpatient care</subject><subject>Inpatients - psychology</subject><subject>Long QT Syndrome - chemically induced</subject><subject>Long QT Syndrome - complications</subject><subject>Long QT Syndrome - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mental Disorders - complications</subject><subject>Mental Disorders - drug therapy</subject><subject>Mental health care</subject><subject>Methadone - adverse effects</subject><subject>Middle Aged</subject><subject>Pharmacology</subject><subject>Prevalence</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Risk Factors</subject><subject>Side effects</subject><subject>Switzerland - epidemiology</subject><subject>Torsades de Pointes - chemically induced</subject><subject>Torsades de Pointes - epidemiology</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1r3DAQhkVpabZp_0IQlEIv3o4kS7J7C9s0XVhIwm4hORlZkhMtXtvRx2H762tnNwn00NMw8Mw7MzwInRGYEyLFNzUMbq62w5wCYXNCQUAh4A2aEc54Jikt3qIZANCs5Oz2BH0IYTu2wCR9j05ozkCwHGbozw-f7rNlZ5K2Bq_67h7fbLDr8LlJbcTXYa8fnIreabzsBhWd7WL4jjcPFvPsziqPF74PIVtbHV3fqRZfLC7xWntrOzeGXaWo-52dEl-y9ngdk9l_RO8a1Qb76VhP0e-fF5vFr2x1dblcnK8ylcsyZtQoUvMy56Wx0BghGwFSAqHcyroQUlAuDIe8sZyymlgJyhSc65ppJQqp2Sn6esgdfP-YbIjVzgVt21Z1tk-hIrnghciJLEb08z_otk9-_OqJKiVQwidKHCg9ve5tUw3e7ZTfVwSqyU412alGO9Vkp3q2Mw6eHeNTvbPmZexZxwh8OQIqaNU2XnXahVeuACqLnI0cO3BPi15v_P_6v7cPqMA</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>R. Girardin, François</creator><creator>Gex-Fabry, Marianne</creator><creator>Berney, Patricia</creator><creator>Shah, Dipen</creator><creator>Gaspoz, Jean-Michel</creator><creator>Dayer, Pierre</creator><general>American Psychiatric Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study</title><author>R. Girardin, François ; Gex-Fabry, Marianne ; Berney, Patricia ; Shah, Dipen ; Gaspoz, Jean-Michel ; Dayer, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a479t-2da1b59459de0fd67f60770125e7b8676256d504fe523b1e70ad855cb3ca687c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Citalopram - adverse effects</topic><topic>Cross-Sectional Studies</topic><topic>Death, Sudden, Cardiac - epidemiology</topic><topic>Electrocardiography</topic><topic>Electrocardiography - drug effects</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Inpatient care</topic><topic>Inpatients - psychology</topic><topic>Long QT Syndrome - chemically induced</topic><topic>Long QT Syndrome - complications</topic><topic>Long QT Syndrome - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mental Disorders - complications</topic><topic>Mental Disorders - drug therapy</topic><topic>Mental health care</topic><topic>Methadone - adverse effects</topic><topic>Middle Aged</topic><topic>Pharmacology</topic><topic>Prevalence</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Risk Factors</topic><topic>Side effects</topic><topic>Switzerland - epidemiology</topic><topic>Torsades de Pointes - chemically induced</topic><topic>Torsades de Pointes - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>R. Girardin, François</creatorcontrib><creatorcontrib>Gex-Fabry, Marianne</creatorcontrib><creatorcontrib>Berney, Patricia</creatorcontrib><creatorcontrib>Shah, Dipen</creatorcontrib><creatorcontrib>Gaspoz, Jean-Michel</creatorcontrib><creatorcontrib>Dayer, Pierre</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>R. Girardin, François</au><au>Gex-Fabry, Marianne</au><au>Berney, Patricia</au><au>Shah, Dipen</au><au>Gaspoz, Jean-Michel</au><au>Dayer, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>170</volume><issue>12</issue><spage>1468</spage><epage>1476</epage><pages>1468-1476</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><coden>AJPSAO</coden><abstract>Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases if a patient taking certain medications has hypokalemia, hepatitis C, HIV, or abnormal T wave morphology.
ObjectiveThe authors aimed to determine the prevalence of drug-induced long QT at admission to a public psychiatric hospital and to document the associated factors using a cross-sectional approach.MethodAll ECG recordings over a 5-year period were reviewed for drug-induced long QT (heart-rate corrected QT ≥500 ms and certain or probable drug imputability) and associated conditions. Patients with drug-induced long QT (N=62) were compared with a sample of patients with normal ECG (N=143).ResultsAmong 6,790 inpatients, 27.3% had abnormal ECG, 1.6% had long QT, and 0.9% qualified as drug-induced long QT case subjects. Sudden cardiac death was recorded in five patients, and torsade de pointes was recorded in seven other patients. Relative to comparison subjects, patients with drug-induced long QT had significantly higher frequencies of hypokalemia, hepatitis C virus (HCV) infection, HIV infection, and abnormal T wave morphology. Haloperidol, sertindole, clotiapine, phenothiazines, fluoxetine, citalopram (including escitalopram), and methadone were significantly more frequent in patients with drug-induced long QT. After adjustment for hypokalemia, HCV infection, HIV infection, and abnormal T wave morphology, the effects of haloperidol, clotiapine, phenothiazines, and citalopram (including escitalopram) remained statistically significant. Receiver operating characteristic curve analysis based on the number of endorsed factors per patient indicated that 85.5% of drug-induced long QT patients had two or more factors, whereas 81.1% of patients with normal ECG had fewer than two factors.ConclusionsDrug-induced long QT and arrhythmia propensity substantially increase when specific psychotropic drugs are administered to patients with hypokalemia, abnormal T wave morphology, HCV infection, and HIV infection.</abstract><cop>Arlington, VA</cop><pub>American Psychiatric Association</pub><pmid>24306340</pmid><doi>10.1176/appi.ajp.2013.12060860</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-953X |
ispartof | The American journal of psychiatry, 2013-12, Vol.170 (12), p.1468-1476 |
issn | 0002-953X 1535-7228 |
language | eng |
recordid | cdi_proquest_miscellaneous_1465864178 |
source | MEDLINE; American Psychiatric Publishing Journals (1997-Present); EZB Electronic Journals Library |
subjects | Adolescent Adult Aged Antipsychotic Agents - adverse effects Biological and medical sciences Case-Control Studies Citalopram - adverse effects Cross-Sectional Studies Death, Sudden, Cardiac - epidemiology Electrocardiography Electrocardiography - drug effects Female General aspects Humans Inpatient care Inpatients - psychology Long QT Syndrome - chemically induced Long QT Syndrome - complications Long QT Syndrome - epidemiology Male Medical sciences Mental Disorders - complications Mental Disorders - drug therapy Mental health care Methadone - adverse effects Middle Aged Pharmacology Prevalence Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Risk Factors Side effects Switzerland - epidemiology Torsades de Pointes - chemically induced Torsades de Pointes - epidemiology |
title | Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T15%3A45%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug-Induced%20Long%20QT%20in%20Adult%20Psychiatric%20Inpatients:%20The%205-Year%20Cross-Sectional%20ECG%20Screening%20Outcome%20in%20Psychiatry%20Study&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=R.%20Girardin,%20Fran%C3%A7ois&rft.date=2013-12-01&rft.volume=170&rft.issue=12&rft.spage=1468&rft.epage=1476&rft.pages=1468-1476&rft.issn=0002-953X&rft.eissn=1535-7228&rft.coden=AJPSAO&rft_id=info:doi/10.1176/appi.ajp.2013.12060860&rft_dat=%3Cproquest_cross%3E1465864178%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1469702158&rft_id=info:pmid/24306340&rfr_iscdi=true |